Using Pulsed Dual-wavelength 595 and 1064 nm Is More Effective in the Management of Hemangiomas

April 2010 | Volume 9 | Issue 4 | Original Article | 310 | Copyright © 2010

Ali Mohammad Saafan PhD and Manal Mohamed Salah MD


Objective: To evaluate the efficacy of application of dual long-pulsed dye/Nd:YAG lasers in the management of skin and mucous membrane infantile hemangiomas.

Background: Management of hemangiomas may be a challenge. Different laser systems have been reported to be of significant help for such cases with variable results.

Patients and Methods: In this study, the authors present a unique sequential laser system, which delivers pulsed dye laser (PDL) 595 nm followed by Nd:YAG 1064 nm, which they have found to be superior and more effective than other reported techniques. Twenty-five cases of infantile hemangiomas in the skin and mucous membrane in the head and neck region were selected to be enrolled in this study. Assessment for progress was achieved clinically.

Results: The authors achieved excellent results in eighteen patients (72%) out of the 25 treated patients, with no recurrence after sixmonth follow-up. Laser application from skin and mucous membrane sides (sandwich technique) decreased number of sessions.

Conclusion: The sequential application of 595 nm PDL followed by 1064 nm Nd:YAG laser can be considered a superior method for management of infantile hemangiomas, especially in the head and neck region, due to its excellent cosmetic results with fewer treatment sessions.

Purchase Original Article

Purchase a single fully formatted PDF of the original manuscript as it was published in the JDD.

Download the original manuscript as it was published in the JDD.

Contact a member of the JDD Sales Team to request a quote or purchase bulk reprints, e-prints or international translation requests.

To get access to JDD's full-text articles and archives, upgrade here.

Save an unformatted copy of this article for on-screen viewing.

Print the full-text of article as it appears on the JDD site.

→ proceed | ↑ close

Related Articles